Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ)
Titel:
Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ)
Auteur:
Affronti, Mary Lou Woodring, Sarah Allen, Karen Kirkpatrick, John Peters, Katherine B. Herndon, James E. McSherry, Frances Healy, Patrick N. Desjardins, Annick Vredenburgh, James J. Friedman, Henry S.